Proteome Sciences PLC Cash Flow Conversion Efficiency

Latest as of December 2025: -0.089x

Proteome Sciences PLC cash flow conversion efficiency. Based on the latest financial reports, Proteome Sciences PLC (PRM) has a cash flow conversion efficiency ratio of -0.089x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX851.00K ≈ $103.54 USD) by net assets (GBX-9.53 Million ≈ $-1.16K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Proteome Sciences PLC (1994–2025)

Cash flow conversion efficiency of Proteome Sciences PLC from 1994 to 2025. This chart illustrates how Proteome Sciences PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Proteome Sciences PLC stock price today for real-time trading data and today's change.

Proteome Sciences PLC Cash Flow Conversion Ratio Explained

Proteome Sciences PLC cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Proteome Sciences PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Proteome Sciences PLC ranked by their cash flow conversion efficiency. Also see Proteome Sciences PLC stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Bumrungrad Hospital Public Company Limited F:BZ7A	0.035x
Fadel Partners Inc LSE:FADL	N/A
Serinus Energy LSE:SENX	0.002x
Digitalbox PLC LSE:DBOX	0.027x
Trafalgar New Homes Plc LSE:TRAF	-0.117x
Philipp Holzmann AG DU:HOZ	N/A
Harmony Energy Income Trust PLC LSE:HEIT	0.003x
Bisichi Mining PLC LSE:BISI	0.027x

Annual Cash Flow Conversion Efficiency for Proteome Sciences PLC (1994–2025)

The table below shows the annual cash flow conversion efficiency of Proteome Sciences PLC from 1994 to 2025. Review PRM free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	GBX-9.53 Million ≈ $-1.16K	GBX-46.00K ≈ $-5.60	0.005x	-96.19%
2024-12-31	GBX-6.52 Million ≈ $-792.81	GBX-826.00K ≈ $-100.50	0.127x	-19.20%
2023-12-31	GBX-3.07 Million ≈ $-373.04	GBX-481.00K ≈ $-58.52	0.157x	+507640.31%
2022-12-31	GBX69.26 Billion ≈ $8.43 Million	GBX2.14 Million ≈ $260.38	0.000x	+172.90%
2021-12-31	GBX70.04 Billion ≈ $8.52 Million	GBX793.00K ≈ $96.49	0.000x	-52.16%
2020-12-31	GBX66.88 Billion ≈ $8.14 Million	GBX1.58 Million ≈ $192.61	0.000x	+100.01%
2019-12-31	GBX65.66 Billion ≈ $7.99 Million	GBX-21.45 Billion ≈ $-2.61 Million	-0.327x	-40.98%
2018-12-31	GBX63.78 Billion ≈ $7.76 Million	GBX-14.78 Billion ≈ $-1.80 Million	-0.232x	-127.58%
2017-12-31	GBX66.02 Billion ≈ $8.03 Million	GBX55.47 Billion ≈ $6.75 Million	0.840x	+3000.54%
2016-12-31	GBX1.09 Trillion ≈ $133.11 Million	GBX-31.70 Billion ≈ $-3.86 Million	-0.029x	-104.09%
2015-12-31	GBX65.86 Billion ≈ $8.01 Million	GBX46.63 Billion ≈ $5.67 Million	0.708x	+845.17%
2014-12-31	GBX65.96 Billion ≈ $8.03 Million	GBX-6.27 Billion ≈ $-762.51K	-0.095x	+47.39%
2013-12-31	GBX63.95 Billion ≈ $7.78 Million	GBX-11.55 Billion ≈ $-1.41 Million	-0.181x	-104.13%
2012-12-31	GBX-766.53K ≈ $-93.26	GBX-3.35 Million ≈ $-408.01	4.375x	+379.37%
2011-12-31	GBX3.30 Million ≈ $401.39	GBX-5.17 Million ≈ $-628.55	-1.566x	-382.40%
2010-12-31	GBX7.22 Million ≈ $878.34	GBX4.00 Million ≈ $487.05	0.555x	+72.36%
2009-12-31	GBX-9.24 Million ≈ $-1.12K	GBX-2.97 Million ≈ $-361.61	0.322x	-56.11%
2008-12-31	GBX-5.62 Million ≈ $-684.28	GBX-4.12 Million ≈ $-501.53	0.733x	-61.23%
2007-12-31	GBX-2.17 Million ≈ $-263.42	GBX-4.09 Million ≈ $-498.00	1.891x	+235.68%
2006-12-31	GBX2.59 Million ≈ $314.88	GBX-3.61 Million ≈ $-438.75	-1.393x	-129.38%
2005-12-31	GBX7.85 Million ≈ $955.24	GBX-4.77 Million ≈ $-580.25	-0.607x	-41.83%
2004-12-31	GBX8.80 Million ≈ $1.07K	GBX-3.77 Million ≈ $-458.72	-0.428x	-4.05%
2003-12-31	GBX11.84 Million ≈ $1.44K	GBX-4.88 Million ≈ $-593.15	-0.412x	-48.86%
2002-12-31	GBX11.84 Million ≈ $1.44K	GBX-3.27 Million ≈ $-398.35	-0.276x	+55.36%
2001-12-31	GBX2.51 Million ≈ $305.27	GBX-1.55 Million ≈ $-189.08	-0.619x	-43.31%
2000-12-31	GBX2.64 Million ≈ $321.21	GBX-1.14 Million ≈ $-138.83	-0.432x	+96.38%
1999-12-31	GBX105.00K ≈ $12.78	GBX-1.25 Million ≈ $-152.58	-11.943x	-698.00%
1998-12-31	GBX1.03 Million ≈ $125.44	GBX-1.54 Million ≈ $-187.74	-1.497x	-233.77%
1997-12-31	GBX2.87 Million ≈ $348.95	GBX-1.29 Million ≈ $-156.47	-0.448x	+91.59%
1996-12-31	GBX321.00K ≈ $39.06	GBX-1.71 Million ≈ $-208.30	-5.333x	-278.00%
1994-10-31	GBX-270.00K ≈ $-32.85	GBX-809.00K ≈ $-98.43	2.996x	--

About Proteome Sciences PLC

LSE:PRM UK Diagnostics & Research

Market Cap

$57.40K

GBX471.73 Million GBX

Market Cap Rank

#31647 Global

#1180 in UK

Share Price

GBX1.35

Change (1 day)

-7.56%

52-Week Range

GBX1.28 - GBX3.51

All Time High

GBX22.25